| Literature DB >> 35457708 |
Jinzi Zhang1, Pu Ge2, Xialei Li3, Mei Yin1, Yujia Wang1, Waikit Ming4, Jinhui Li5, Pei Li6, Xinying Sun7, Yibo Wu7.
Abstract
Objective: This study aims to investigate the differences in public vaccination preference for the COVID-19 vaccine with different personality characteristics.Entities:
Keywords: COVID-19; big five personality traits; discrete choice experiment; latent profile analysis; vaccine preference
Mesh:
Substances:
Year: 2022 PMID: 35457708 PMCID: PMC9031452 DOI: 10.3390/ijerph19084842
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Vaccination of attributes and their respective levels in this discrete choice experiment.
| Attributes | Levels of Attributes | Explain |
|---|---|---|
| Vaccine varieties | mRNA vaccine | Several common vaccines are produced by countries at present. |
| Adenovirus vector vaccine | ||
| Inactivated vaccine | ||
| Adverse effect | Very mild | The extent of possible side effects of vaccination with COVID-19. |
| mild | ||
| Moderate | ||
| Efficacy | 55% | Effectiveness of vaccination against infection with COVID-19 |
| 65% | ||
| 75% | ||
| 85% | ||
| 95% | ||
| Time for the vaccine to start working | 5 days | Time from the time the COVID-19 vaccine is administered until the time the vaccine begins to work in the body. |
| 10 days | ||
| 15 days | ||
| 20 days | ||
| The duration of vaccine works | 5 months | Duration of time that a COVID-19 vaccine takes effect in the body until it ceases to be effective. |
| 10 months | ||
| 15 months | ||
| 20 months | ||
| The cost of vaccination | $0 | The total cost of vaccinating COVID-19 |
| $50 | ||
| $100 | ||
| $150 | ||
| $200 |
An example scenario of the choice-based conjoint in the questionnaire; scenario #1/11.
| Attributes | Vaccine A | Vaccine B | Neither |
|---|---|---|---|
| Vaccine varieties | Inactivated vaccine | mRNA vaccine | Neither |
| Adverse effect | mild | Very mild | |
| Efficacy | 95% | 55% | |
| Time for the vaccine to start working | 20 days | 10 days | |
| The duration of vaccine works | 5 months | 20 months | |
| The cost of vaccination | $0 | $0 |
Latent Profile Model Information Criteria, Likelihood Ratio Test, and Entropy (N = 1200).
| Number of Profiles | AIC | BIC | ABIC | Entropy | |
|---|---|---|---|---|---|
| 1 | 21,759.116 | 21,810.017 | 21,778.253 | ||
| 2 | 21,535.778 | 21,617.22 | 21,566.397 | 0.677 | 0.6492 |
| 3 | 21,439.248 | 21,551.23 | 21,481.349 | 0.722 | 0.0215 |
| 4 | 21,405.553 | 21,548.076 | 21,459.137 | 0.708 | 0.1956 |
| 5 | 21,359.904 | 21,532.967 | 21,424.97 | 0.719 | 0.1031 |
Figure 1Descriptive statistics for the three-profile model.
Demographic characteristics of different personality portraits.
| Demographic Items | General and Stable Type ( | Conscientious and Agreeable Type ( | Open and Extroverted Type ( | F Value | |
|---|---|---|---|---|---|
| Gender (%) | 2.149 | 0.117 | |||
| Male | 408 (56.1%) | 37 (32.5) | 50 (38.5%) | ||
| Female | 544 (33.3%) | 77 (67.5) | 80 (61.5%) | ||
| Other | 4 (7.9%) | 0 (0%) | 0 (0%) | ||
| Age interval in years (%) | 2.164 | 0.115 | |||
| 18–40 | 592 (61.9%) | 54 (47.4) | 87 (66.9%) | ||
| 41–60 | 225 (23.5%) | 48 (42.1) | 29 (22.3%) | ||
| Above 60 | 139 (14.5%) | 12 (10.5) | 14 (10.8%) | ||
| Highest educational level (%) | 2.376 | 0.093 | |||
| Pre-primary education or primary school education | 77 (8.1%) | 12 (10.5%) | 4 (3.1%) | ||
| Middle school education | 127 (13.3%) | 11 (9.6%) | 12 (9.2%) | ||
| High school education | 159 (16.6%) | 11 (9.6%) | 25 (19.2%) | ||
| Vocational school education | 164 (17.2%) | 33 (28.9%) | 16 (12.3%) | ||
| Bachelor’s degree | 360 (37.7%) | 41 (36%) | 66 (50.8%) | ||
| Master’s degree | 56 (5.9%) | 4 (3.5%) | 6 (4.6%) | ||
| Ph.D. degree | 13 (1.4%) | 2 (1.8%) | 1 (0.8%) | ||
| Annual salary level (%) | 1.447 | 0.236 | |||
| Under USD 10,000 | 619 (64.7%) | 64 (56.1%) | 86 (66.2%) | ||
| USD 10,001–30,000 | 261 (27.3%) | 38 (33.3%) | 34 (26.2%) | ||
| USD 30,001–50,000 | 52 (5.4%) | 9 (7.9%) | 8 (6.2%) | ||
| Above USD 50,000 | 24 (2.5%) | 3 (2.6%) | 2 (1.5%) | ||
| Acceptance of vaccination (totally unwilling, 0–totally willing, 10) | 4.669 | 0.01 | |||
| Average | 8.96 | 9.18 | 9.45 | ||
Figure 2Percentage importance of attributes in latent profile analysis.
General results of the conditional logit model. Comparison of overall and three categories of respondents with different personality traits in attributes levels utility and odds ratios.
| Attributes and Levels | Overall, | General and Stable Type, | Conscientious and Agreeable Type, | Open and Extroverted Type, | ||||
|---|---|---|---|---|---|---|---|---|
| Coefficient | Odds Ratio (95%CI) | Coefficient | Odds Ratio (95%CI) | Coefficient | Odds Ratio (95%CI) | Coefficient | Odds Ratio (95%CI) | |
| Varieties | ||||||||
| mRNA vaccines | −0.081 *** | REF | −0.064 ** | REF | −0.183 * | REF | −0.126 | REF |
| Adenovirus vector vaccines | −0.117 *** | 0.964 (0.925–1.006) | −0.085 *** | 0.979 (0.934–1.026) | −0.255 *** | 0.930 (0.810–1.069) | −0.236 *** | 0.896 (0.788–1.020) |
| Inactivated vaccines | 0.198 *** | 1.32 (1.267–1.376) | 0.149 *** | 1.237 (1.181–1.296) | 0.437 *** | 1.859 (1.624–2.128) | 0.362 *** | 1.629 (1.436–1.848) |
| Adverse effect | ||||||||
| very mild | 0.153 *** | REF | 0.156 *** | REF | 0.165 * | REF | 0.129 * | REF |
| mild | 0.099 *** | 0.947 (0.909–0.988) | 0.080 ** | 0.926 (0.884–0.971) | 0.118 | 0.954 (0.833–1.093) | 0.231 *** | 1.108 (0.977–1.256) |
| moderate | −0.253 *** | 0.666 (0.639–0.695) | −0.236 *** | 0.676 (0.644–0.709) | −0.283 *** | 0.639 (0.554–0.737) | −0.359 *** | 0.614 (0.538–0.700) |
| Efficacy | ||||||||
| 55% | −0.601 *** | REF | −0.574 *** | REF | −0.726 *** | REF | −0.700 *** | REF |
| 65% | −0.282 *** | 1.375 (1.292–1.464) | −0.289 *** | 1.330 (1.239–1.428) | −0.155 | 1.770 (1.444–2.169) | −0.387 *** | 1.367 (1.129–1.656) |
| 75% | 0.008 | 1.839 (1.731–1.953) | −0.028 | 1.726 (1.612–1.848) | 0.165 | 2.438 (2.006–2.962) | 0.150 | 2.340 (1.947–2.811) |
| 85% | 0.289 *** | 2.435 (2.295–2.583) | 0.312 *** | 2.426 (2.270–2.592) | 0.244 * | 2.638 (2.166–3.213) | 0.180 | 2.410 (2.010–2.888) |
| 95% | 0.585 *** | 3.273 (3.086–3.473) | 0.579 *** | 3.166 (2.963–3.383) | 0.473 *** | 3.318 (2.725–4.040) | 0.756 *** | 4.289 (3.578–5.140) |
| Start working | ||||||||
| 5 days | −0.017 | REF | −0.010 | REF | −0.160 | REF | 0.049 | REF |
| 10 days | 0.021 | 1.039 (0.987–1.095) | 0.013 | 1.024 (0.966–1.085) | 0.109 | 1.309 (1.104–1.552) | 0.002 | 0.954 (0.815–1.116) |
| 15 days | 0.049 | 1.069 (1.015–1.125) | 0.060 * | 1.073 (1.012–1.138) | 0.020 | 1.197 (1.007–1.424) | 0.009 | 0.961 (0.822–1.124) |
| 20 days | −0.053 * | 0.965 (0.916–1.017) | −0.064 * | 0.948 (0.894–1.006) | 0.030 | 1.210 (1.017–1.438) | −0.059 | 0.897 (0.767–1.049) |
| Duration | ||||||||
| 5 months | −0.282 *** | REF | −0.274 *** | REF | −0.332 *** | REF | −0.317 *** | REF |
| 10 months | −0.005 | 1.319 (1.252–1.389) | 0.002 | 1.318 (1.244–1.398) | −0.024 | 1.361 (1.145–1.618) | −0.012 | 1.356 (1.160–1.585) |
| 15 months | 0.104 *** | 1.471 (1.397–1.549) | 0.115 *** | 1.476 (1.393–1.564) | 0.089 | 1.523 (1.283–1.807) | 0.021 | 1.402 (1.199–1.640) |
| 20 months | 0.184 *** | 1.593 (1.514–1.677) | 0.157 *** | 1.538 (1.452–1.630) | 0.267 ** | 1.819 (1.538–2.152) | 0.308 *** | 1.867 (1.600–2.178) |
| The cost | ||||||||
| $0 | 0.924 *** | REF | 0.948 *** | REF | 0.974 *** | REF | 0.751 *** | REF |
| $50 | 0.217 *** | 0.493 (0.465–0.523) | 0.232 *** | 0.489 (0.458–0.522) | 0.160 | 0.443 (0.365–0.538) | 0.157 | 0.522 (0.461–0.661) |
| $100 | −0.128 *** | 0.349 (0.329–0.371) | −0.151 *** | 0.333 (0.311–0.357) | −0.126 | 0.333 (0.272–0.407) | 0.032 | 0.487 (0.406–0.585) |
| $150 | −0.294 *** | 0.296 (0.278–0.315) | −0.292 *** | 0.290 (0.270–0.311) | −0.258 * | 0.292 (0.238–0.358) | −0.378 *** | 0.323 (0.267–0.391) |
| $200 | −0.719 *** | 0.193 (0.181–0.207) | −0.737 *** | 0.186 (0.172–0.200) | −0.749 *** | 0.179 (0.143–0.224) | −0.562 *** | 0.269 (0.221–0.328) |
REF: Reference level; * p < 0.05 ** p < 0.01 *** p < 0.001.
WTP a of respondents with different personality traits b.
| Attributes and Levels | Overall | General | Conscientious | Open and Extroverted Type ( |
|---|---|---|---|---|
| Varieties | ||||
| Adenovirus vector vaccines | REF | REF | REF | REF |
| mRNA vaccines | 1.84 | 0.08 | 8.03 | 3.96 |
| Inactivated vaccines | 26.25 | 34.45 | 59.18 | 75.10 |
| Adverse effect | ||||
| moderate | REF | REF | REF | REF |
| very mild | 30.55 | 55.96 | 50.00 | 44.80 |
| mild | 20.00 | 38.04 | 48.54 | 63.57 |
| Efficacy | ||||
| 55% | REF | REF | REF | REF |
| 65% | 9.35 | 17.55 | 25.15 | 21.09 |
| 75% | 16.58 | 31.51 | 40.75 | 84.28 |
| 85% | 66.38 | 73.83 | 62.61 | 88.28 |
| 95% | 222.36 | 115.53 | 94.86 | 162.34 |
| Start working | ||||
| 5 days | REF | REF | REF | REF |
| 10 days | −0.38 | −3.87 | 30.18 | 3.81 |
| 15 days | 0.20 | −0.48 | 23.98 | −1.46 |
| 20 days | −3.38 | −6.50 | 18.75 | 0.59 |
| Duration | ||||
| 5 months | REF | REF | REF | REF |
| 10 months | 19.22 | 37.23 | 7.68 | 37.01 |
| 15 months | 33.28 | 68.80 | 31.98 | 50.29 |
| 20 months | 62.28 | 75.39 | 61.72 | 80.79 |
a WTP: willingness to pay; b Negative currency values refer to the amount that respondents were willing to pay for another level.